113 related articles for article (PubMed ID: 1177408)
1. Changes of fractional renal clearance of magnesium after spironolactone administration in normal subjects.
Mountokalakis T; Merikas G; Skipelitis P; Vardakis M; Sevastos N; Alivisatos J
Klin Wochenschr; 1975 Jul; 53(13):633-5. PubMed ID: 1177408
[TBL] [Abstract][Full Text] [Related]
2. Attenuation by spironolactone of the magnesiuric effect of acute frusemide administration in patients with liver cirrhosis and ascites.
Stergiou GS; Mayopoulou-Symvoulidou D; Mountokalakis TD
Miner Electrolyte Metab; 1993; 19(2):86-90. PubMed ID: 8377729
[TBL] [Abstract][Full Text] [Related]
3. Renal handling of magnesium in transplanted children under cyclosporin A treatment.
Krull F; Hoyer PF; Offner G; Brodehl J
Eur J Pediatr; 1988 Nov; 148(2):148-51. PubMed ID: 3069471
[TBL] [Abstract][Full Text] [Related]
4. Effect of spironolactone on the renal clearance of digoxin in dogs.
O'Brien MS; Salamone LF; Gibson TP
J Pharmacol Exp Ther; 1985 Jul; 234(1):190-4. PubMed ID: 4009501
[TBL] [Abstract][Full Text] [Related]
5. Acute effect of hydrochlorothiazide on renal calcium and magnesium handling in postmenopausal women.
Stefíková K; Spustová V; Dzúrik R
Physiol Res; 1999; 48(4):327-30. PubMed ID: 10638687
[TBL] [Abstract][Full Text] [Related]
6. Renal function and magnesium clearance in young and old cows given potassium chloride and sodium citrate.
Deetz LE; Tucker RE; Mitchell GE; DeGregorio RM
J Anim Sci; 1982 Sep; 55(3):680-9. PubMed ID: 7130070
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporin-induced hypomagnesaemia and renal magnesium wasting in rats.
Wong NL; Dirks JH
Clin Sci (Lond); 1988 Nov; 75(5):509-14. PubMed ID: 3254764
[TBL] [Abstract][Full Text] [Related]
8. Effects on muscle electrolytes of potassium and magnesium infusions, spironolactone medication and operation in a case of primary aldosteronism.
Dyckner T; Wester PO
Acta Med Scand; 1979; 206(1-2):137-40. PubMed ID: 484255
[TBL] [Abstract][Full Text] [Related]
9. Correction of hypokalemia with antialdosterone therapy in Gitelman's syndrome.
Colussi G; Rombolà G; De Ferrari ME; Macaluso M; Minetti L
Am J Nephrol; 1994; 14(2):127-35. PubMed ID: 8080005
[TBL] [Abstract][Full Text] [Related]
10. Renal reabsorption of magnesium and calcium by cattle with renal tubular dysplasia.
Ohba Y; Kitoh K; Nakamura H; Okuda H; Kunieda T; Sasaki Y; Kitagawa H
Vet Rec; 2002 Sep; 151(13):384-7. PubMed ID: 12403519
[TBL] [Abstract][Full Text] [Related]
11. [Effect of diuretics on the renal excretion of magnesium].
Sotorník I; Schück O
Cas Lek Cesk; 1975 Apr; 114(16):500-5. PubMed ID: 1131840
[No Abstract] [Full Text] [Related]
12. Dose-dependent reduction in renal magnesium clearance by amiloride during frusemide-induced diuresis in rats.
Devane J; Ryan MP
Br J Pharmacol; 1983 Nov; 80(3):421-8. PubMed ID: 6640198
[TBL] [Abstract][Full Text] [Related]
13. Effect of an increase in the plasma potassium concentration on renal magnesium handling in healthy volunteers.
de Valk HW; van Rijn HJ; Wielders JP; Koomans HA
Nephrol Dial Transplant; 1998 Jan; 13(1):53-8. PubMed ID: 9481715
[TBL] [Abstract][Full Text] [Related]
14. Intrarenal sodium handling during chronic spironolactone treatment.
Roos JC; Dorhout Mees EJ; Koomans HA; Boer P
Nephron; 1984; 38(4):226-32. PubMed ID: 6514071
[TBL] [Abstract][Full Text] [Related]
15. Silicon metabolism. I. Some aspects of renal silicon handling in normal man.
Berlyne GM; Adler AJ; Ferran N; Bennett S; Holt J
Nephron; 1986; 43(1):5-9. PubMed ID: 3703066
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology of spironolactone-induced gynecomastia.
Rose LI; Underwood RH; Newmark SR; Kisch ES; Williams GH
Ann Intern Med; 1977 Oct; 87(4):398-403. PubMed ID: 907238
[TBL] [Abstract][Full Text] [Related]
17. [Urinary excretion of sodium and potassium after administration of aldosterone antagonist (Aldactone) in newborn infants and infants].
Solc J
Cesk Pediatr; 1974 Apr; 29(4):206-7. PubMed ID: 4830782
[No Abstract] [Full Text] [Related]
18. A comparison of the potassium and magnesium-sparing properties of amiloride and spironolactone in diuretic-treated normal subjects.
Murdoch DL; Forrest G; Davies DL; McInnes GT
Br J Clin Pharmacol; 1993 Apr; 35(4):373-8. PubMed ID: 8485017
[TBL] [Abstract][Full Text] [Related]
19. Magnesium- and potassium-sparing effects of amiloride. Review and recent findings.
Ryan MP
Magnesium; 1984; 3(4-6):274-88. PubMed ID: 6536837
[TBL] [Abstract][Full Text] [Related]
20. Renal calcium and magnesium handling in water immersion in nephrotic patients.
Brown C; Sutton JV; Adler A; Feinroth MV; Feinroth M; Friedman EA; Berlyne GM
Nephron; 1983; 33(1):17-20. PubMed ID: 6835450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
